Real-world outcomes with immuno-oncology (IO) therapies: A prospective, observational cohort study in patients (pts) with advanced melanoma (OPTIMIzE).

被引：0
|
作者：
Kirkwood, John M.
Kottschade, Lisa A.
McWilliams, Robert R.
Khushalani, Nikhil I.
Jang, Sekwon
Hallmeyer, Sigrun
McDermott, David F.
Tawbi, Hussein Abdul-Hassan
Wan, Yin
Wang, Rosa
Ritchings, Corey
Rao, Sumati
Ramsey, Scott
机构：
[1] Univ Pittsburgh, Melanoma Program, UPMC Hillman Canc Ctr, Pittsburgh, PA USA
[2] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA
[3] Mayo Clin, Rochester, MN USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[5] Virginia Commonwealth Univ, Inova Schar Canc Inst, Fairfax, VA USA
[6] Advocate Med Grp, Park Ridge, IL USA
[7] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[8] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[9] Bristol Myers Squibb, Princeton, NJ USA
[10] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e14144
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14144
引用
收藏
页数：2
相关论文
共 50 条
  • [11] An observational study of patients with advanced melanoma receiving pembrolizumab in a real-world US community oncology practice.
    Cowey, Charles Lance
    Liu, Frank Xiaoqing
    Black-Shinn, Jenny
    Stevinson, Kendall Lee
    Boyd, Marley
    Patt, Debra A.
    Ebbinghaus, Scot
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [12] Real-world clinical outcomes of anticancer treatments in patients with advanced melanoma in China: retrospective, observational study
    Cui, Chuanliang
    Yan, Xieqiao
    Liu, Shusen
    Deitz, Anne C.
    Si, Lu
    Chi, Zhihong
    Sheng, Xinan
    Lian, Bin
    Li, Jianfeng
    Ge, Jun
    Wang, Xuan
    Mao, Lili
    Tang, Bixia
    Zhou, Li
    Bai, Xue
    Li, Siming
    Li, Ben
    Wu, Haiyan
    Guo, Jun
    INTERNATIONAL JOURNAL OF SURGERY-ONCOLOGY, 2019, 4 (06):
  • [13] REAL-WORLD TREATMENT PATTERNS FOR PATIENTS WITH METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA (MHNSCC) TREATED WITH IMMUNO-ONCOLOGY (IO) THERAPY
    Huang, H.
    Shenolikar, R.
    Seal, B.
    Tse, J.
    Burudpakdee, C.
    VALUE IN HEALTH, 2019, 22 : S390 - S390
  • [14] Real-world safety of first-line immuno-oncology combination therapies for advanced non-small-cell lung cancer
    Betts, Keith A.
    Gao, Sophie
    Ray, Saurabh
    Schoenfeld, Adam J.
    FUTURE ONCOLOGY, 2024, 20 (13) : 851 - 862
  • [15] Improved Survival of Real-world Japanese Patients With Advanced Renal Cell Carcinoma Treated With Immuno-oncology Combination Therapy
    Ueda, K. O. S. U. K. E.
    Suekane, S. H. I. G. E. T. A. K. A.
    Kurose, H. I. R. O. F. U. M. I.
    Ito, N. A. O. K. I.
    Ogasawara, N. A. O. Y. U. K., I
    Hiroshige, T. A. S. U. K. U.
    Chikui, K. A. T. S. U. A. K., I
    Ejima, K. A. Z. U. H. I. S. A.
    Uemura, K. E. I. I. C. H. I. R. O.
    Nakiri, M. A. K. O. T. O.
    Nishihara, K. I. Y. O. A. K. I.
    Matsuo, M. I. T. S. U. N. O. R. I.
    Igawa, T. S. U. K. A. S. A.
    ANTICANCER RESEARCH, 2022, 42 (09) : 4573 - 4580
  • [16] Real-World Treatment Patterns and Outcomes in ALK plus NSCLC Patients Receiving Immuno-Oncology Therapy in the United States
    Pan, X.
    Lin, H.
    Yin, Y.
    Cheng, M.
    Baumann, P.
    Jahanzeb, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S883 - S883
  • [17] Real-World (RW) Predictors of Immuno-Oncology (IO) vs Chemotherapy (C) Use in Advanced Non-Small Cell Lung Cancer (aNSCLC)
    Radtchenko, J.
    Korytowsky, B.
    Nwokeji, E.
    Tue, K.
    Feinberg, B.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S889 - S889
  • [18] Real-world experience of pembrolizumab in patients with advanced melanoma: A large retrospective observational study
    Liu, F. X.
    Ou, W.
    Diede, S. J.
    Whitman, E. D.
    ANNALS OF ONCOLOGY, 2018, 29
  • [19] Real-world experience with pembrolizumab in patients with advanced melanoma A large retrospective observational study
    Liu, Frank Xiaoqing
    Ou, Wanmei
    Diede, Scott J.
    Whitman, Eric D.
    MEDICINE, 2019, 98 (30) : e16542
  • [20] REAL-WORLD OUTCOMES OF IPILIMUMAB IN PATIENTS WITH ADVANCED MELANOMA IN THE NETHERLANDS
    Leeneman, B.
    Jochems, A.
    Schouwenburg, M.
    Aarts, M.
    van Akkooi, A.
    van den Berkmortel, F.
    van den Eertwegh, A.
    Groenewegen, G.
    de Groot, J.
    Haanen, J.
    van der Hoeven, J.
    Hospers, G.
    Kapiteijn, H.
    Koornstra, R.
    Kruit, W.
    Louwman, M.
    Piersma, D.
    van Rijn, R.
    ten Tije, A.
    Vreugdenhil, G.
    Wouters, M.
    van Zeijl, M.
    Franken, M.
    Uyl-de Groot, C.
    VALUE IN HEALTH, 2016, 19 (07) : A708 - A709
12345